Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Novartis ADR | NVS | Nov 27, 2024 | 104.87 | +1.02 |
Novavax | NVAX | Nov 27, 2024 | 8.62 | -1.49 |
Novo Integrated Sciences | NVOS | Nov 27, 2024 | 0.17 | 0.00 |
Novo Nordisk ADR | NVO | Nov 27, 2024 | 106.13 | 0.00 |
NovoCure | NVCR | Nov 27, 2024 | 19.69 | +10.12 |
Novonix ADR | NVX | Nov 27, 2024 | 1.98 | -26.39 |
NRG Energy | NRG | Nov 27, 2024 | 98.89 | -2.24 |
NRx Pharmaceuticals | NRXP | Nov 27, 2024 | 1.29 | +1.57 |
NSTS Bancorp | NSTS | Nov 27, 2024 | 11.20 | -0.71 |
Nu Holdings | NU | Nov 27, 2024 | 13.53 | -2.94 |
Nu Skin Enterprises | NUS | Nov 27, 2024 | 7.69 | +3.36 |
Nuburu | BURU | Nov 27, 2024 | 0.46 | +2.06 |
NuCana ADR | NCNA | Nov 27, 2024 | 1.29 | -3.01 |
Nucor | NUE | Nov 27, 2024 | 154.77 | +0.50 |
Nukkleus | NUKK | Nov 27, 2024 | 1.66 | +3.44 |
Nurix Therapeutics | NRIX | Nov 27, 2024 | 21.23 | -2.57 |
NuScale Power | SMR | Nov 27, 2024 | 28.06 | +6.53 |
Nustar Energy C Pref | NS-C | Nov 27, 2024 | 24.99 | 0.00 |
Nutanix A | NTNX | Nov 27, 2024 | 66.70 | -7.81 |
Nutex Health | NUTX | Nov 27, 2024 | 36.92 | +5.49 |
Nutriband | NTRB | Nov 27, 2024 | 4.85 | +1.68 |
Nutrien | NTR | Nov 27, 2024 | 46.09 | +0.41 |
Nuvalent A | NUVL | Nov 27, 2024 | 96.76 | +0.48 |
Nuvation Bio A | NUVB | Nov 27, 2024 | 2.89 | 0.00 |
Nuvectis Pharma | NVCT | Nov 27, 2024 | 5.28 | +2.52 |
Nuveen Amtfree Municipal Credit Income Fund | NVG | Nov 27, 2024 | 13.13 | +1.00 |
Nuveen Amtfree Municipal Value Fund | NUW | Nov 27, 2024 | 13.94 | +0.36 |
Nuveen Amtfree Quality Municipal Income Fund | NEA | Nov 27, 2024 | 11.82 | +0.85 |
Nuveen Arizona Quality Municipal Fund | NAZ | Nov 27, 2024 | 12.21 | +0.14 |
Nuveen California Amtfree Quality Municipal Income Fund | NKX | Nov 27, 2024 | 12.85 | -0.08 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.